Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design
Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is an important threat as it causes serious hospital and community acquired infections with deathly outcomes oftentimes, therefore, development of new treatments against this bacterium is a priority. Shikimate kinase, an enzyme in...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b64edf9ce0dd45f1a826e2f0774f55c1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b64edf9ce0dd45f1a826e2f0774f55c1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b64edf9ce0dd45f1a826e2f0774f55c12021-11-11T18:40:23ZFinding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design10.3390/molecules262167361420-3049https://doaj.org/article/b64edf9ce0dd45f1a826e2f0774f55c12021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6736https://doaj.org/toc/1420-3049Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is an important threat as it causes serious hospital and community acquired infections with deathly outcomes oftentimes, therefore, development of new treatments against this bacterium is a priority. Shikimate kinase, an enzyme in the shikimate pathway, is considered a good target for developing antimicrobial drugs; this is given because of its pathway, which is essential in bacteria whereas it is absent in mammals. In this work, a computer-assisted drug design strategy was used to report the first potentials inhibitors for Shikimate kinase from methicillin-resistant <i>Staphylococcus aureus</i> (SaSK), employing approximately 5 million compounds from ZINC15 database. Diverse filtering criteria, related to druglike characteristics and virtual docking screening in the shikimate binding site, were performed to select structurally diverse potential inhibitors from SaSK. Molecular dynamics simulations were performed to elucidate the dynamic behavior of each SaSK–ligand complex. The potential inhibitors formed important interactions with residues that are crucial for enzyme catalysis, such as Asp37, Arg61, Gly82, and Arg138. Therefore, the compounds reported provide valuable information and can be seen as the first step toward developing SaSK inhibitors in the search of new drugs against MRSA.Lluvia Rios-SotoAlfredo Téllez-ValenciaErick Sierra-CamposMónica Valdez-SolanaJorge Cisneros-MartínezMarcelo Gómez Palacio-GastélumAdriana Castillo-VillanuevaClaudia Avitia-DomínguezMDPI AGarticleMRSAshikimate kinasevirtual screeningmolecular dynamicsADME-Tox propertiesOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6736, p 6736 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
MRSA shikimate kinase virtual screening molecular dynamics ADME-Tox properties Organic chemistry QD241-441 |
| spellingShingle |
MRSA shikimate kinase virtual screening molecular dynamics ADME-Tox properties Organic chemistry QD241-441 Lluvia Rios-Soto Alfredo Téllez-Valencia Erick Sierra-Campos Mónica Valdez-Solana Jorge Cisneros-Martínez Marcelo Gómez Palacio-Gastélum Adriana Castillo-Villanueva Claudia Avitia-Domínguez Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design |
| description |
Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is an important threat as it causes serious hospital and community acquired infections with deathly outcomes oftentimes, therefore, development of new treatments against this bacterium is a priority. Shikimate kinase, an enzyme in the shikimate pathway, is considered a good target for developing antimicrobial drugs; this is given because of its pathway, which is essential in bacteria whereas it is absent in mammals. In this work, a computer-assisted drug design strategy was used to report the first potentials inhibitors for Shikimate kinase from methicillin-resistant <i>Staphylococcus aureus</i> (SaSK), employing approximately 5 million compounds from ZINC15 database. Diverse filtering criteria, related to druglike characteristics and virtual docking screening in the shikimate binding site, were performed to select structurally diverse potential inhibitors from SaSK. Molecular dynamics simulations were performed to elucidate the dynamic behavior of each SaSK–ligand complex. The potential inhibitors formed important interactions with residues that are crucial for enzyme catalysis, such as Asp37, Arg61, Gly82, and Arg138. Therefore, the compounds reported provide valuable information and can be seen as the first step toward developing SaSK inhibitors in the search of new drugs against MRSA. |
| format |
article |
| author |
Lluvia Rios-Soto Alfredo Téllez-Valencia Erick Sierra-Campos Mónica Valdez-Solana Jorge Cisneros-Martínez Marcelo Gómez Palacio-Gastélum Adriana Castillo-Villanueva Claudia Avitia-Domínguez |
| author_facet |
Lluvia Rios-Soto Alfredo Téllez-Valencia Erick Sierra-Campos Mónica Valdez-Solana Jorge Cisneros-Martínez Marcelo Gómez Palacio-Gastélum Adriana Castillo-Villanueva Claudia Avitia-Domínguez |
| author_sort |
Lluvia Rios-Soto |
| title |
Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design |
| title_short |
Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design |
| title_full |
Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design |
| title_fullStr |
Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design |
| title_full_unstemmed |
Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant <i>Staphylococcus aureus</i> through Computer-Assisted Drug Design |
| title_sort |
finding the first potential inhibitors of shikimate kinase from methicillin resistant <i>staphylococcus aureus</i> through computer-assisted drug design |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/b64edf9ce0dd45f1a826e2f0774f55c1 |
| work_keys_str_mv |
AT lluviariossoto findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT alfredotellezvalencia findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT ericksierracampos findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT monicavaldezsolana findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT jorgecisnerosmartinez findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT marcelogomezpalaciogastelum findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT adrianacastillovillanueva findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign AT claudiaavitiadominguez findingthefirstpotentialinhibitorsofshikimatekinasefrommethicillinresistantistaphylococcusaureusithroughcomputerassisteddrugdesign |
| _version_ |
1718431782424018944 |